IP Library Granted Patent US 7,205,006
Granted Patent B2
US 7,205,006 · App. 10/669,416 · Granted Apr 17, 2007

Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same

Assignee: Prime Pharmaceutical Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,205,006
App. No.
10/669,416
Granted
Apr 17, 2007
Kind
B2
Abstract

A skin treatment composition comprising a Mahonia aquifolium extract in a liposome delivery system. The Mahonia aquifolium extract is present in the skin treatment composition in a range of from 5% to 20% by weight of the total composition. The skin treatment composition is particularly effective in the treatment of psoriasis, eczema and other dry skin conditions. The invention further provides a process for obtaining an extract of Mahonia aquifolium.

Claims (3)

1. A skin treatment composition comprising an extract of Mahonia aquifolium in a liposome delivery system, wherein the extract comprises a hydroalcoholic extract of the bark and twigs of Mahonia aquifolium , which is obtained by extracting the bark and twigs of Mahonia aquifolium with a hydroalcoholic solvent at a pressure of 3–6 psi and a temperature of 40° C.–50° C.

2. A skin treatment composition as claimed in claim 1 wherein the extract of Mahonia aquifolium is present in a concentration of from 5% to 20% by weight of the total composition.

3. A skin treatment composition as claimed in claim 1 wherein the extract of Mahonia aquifolium is present in a concentration of 10% by weight of the total composition.

Assignments (3)
RELEASE OF SECURITY AGREEMENT RECORDED 3/16/09, R/F 02239/0570 Recorded May 20, 2009
From: LIFE SCIENCES OPPORTUNITIES FUND II, L.P.; LIFE SCIENCES OPPORTUNITIES FUND (INSTITUTIONAL) II, L.P.
To: IGI LABORATORIES INC.; IMMUNOGENETICS, INC.
Reel/Frame 022708/0091 →
SECURITY AGREEMENT Recorded Mar 16, 2009
From: IGI LABORATORIES, INC.; IMMUNOGENETICS, INC.
To: LIFE SCIENCES OPPORTUNITIES FUND II, L.P.; LIFE SCIENCES OPPORTUNITIES FUND (INSTITUTIONAL) II, L.P.
Reel/Frame 022399/0576 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2004
From: MILLS, ROBERT; MATHUR, RAJIV; LAWRENCE, NADYA
To: PRIME PHARMACEUTICAL CORPORATION
Reel/Frame 015852/0833 →
Continuity (1)
Related Publication 20050069576A1 · Mar 31, 2005